Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Option Care Health (OPCH) Receivables (2016 - 2025)

Historic Receivables for Option Care Health (OPCH) over the last 17 years, with Q3 2025 value amounting to $475.1 million.

  • Option Care Health's Receivables rose 1060.39% to $475.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $475.1 million, marking a year-over-year increase of 1060.39%. This contributed to the annual value of $515.0 million for FY2024, which is 1034.26% up from last year.
  • As of Q3 2025, Option Care Health's Receivables stood at $475.1 million, which was up 1060.39% from $482.3 million recorded in Q2 2025.
  • Over the past 5 years, Option Care Health's Receivables peaked at $574.6 million during Q1 2024, and registered a low of $323.9 million during Q1 2021.
  • Moreover, its 5-year median value for Receivables was $418.3 million (2021), whereas its average is $425.0 million.
  • Per our database at Business Quant, Option Care Health's Receivables skyrocketed by 4514.7% in 2024 and then plummeted by 1705.4% in 2025.
  • Over the past 5 years, Option Care Health's Receivables (Quarter) stood at $418.3 million in 2021, then rose by 14.51% to $479.0 million in 2022, then fell by 2.56% to $466.8 million in 2023, then grew by 10.34% to $515.0 million in 2024, then fell by 7.75% to $475.1 million in 2025.
  • Its Receivables stands at $475.1 million for Q3 2025, versus $482.3 million for Q2 2025 and $476.6 million for Q1 2025.